Search results for "Phase 3 clinical trial"

Breast Cancer Recurrence Risk Persists 20 Years Post-Treatment, Underscoring Need for Long-Term Prevention

Breast Cancer Recurrence Risk Persists 20 Years Post-Treatment, Underscoring Need for Long-Term Prevention

Breast cancer remains a disease where the risk of recurrence is difficult to eliminate entirely, even after successful surgery and chemotherapy.
Experimental Cancer Drug ACR-2316 Triggers Complete Remission in Advanced Lung Cancer Patient

Experimental Cancer Drug ACR-2316 Triggers Complete Remission in Advanced Lung Cancer Patient

An advanced lung cancer patient who had previously undergone multiple rounds of systemic therapy achieved a "complete response" after receiving a...
“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

“Half the Price of Mounjaro”: South Korea’s First Homegrown Obesity Drug Epe Enters the Market

The first domestically developed obesity medication is entering South Korea’s weight-loss market, long dominated by...
Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau

Internal Radiation Treatment Could Expand Pancreatic Cancer Surgery Options as Samsung Medical Center Partners with Alpha Tau

Pancreatic cancer carries a five-year relative survival rate of just 17.0%, the lowest among all major cancers,...
FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

FDA Clears Trial for Next-Gen CAR-T Therapy That Creates Cancer-Fighting Cells Inside Patients

CAR-T therapy for blood cancers conventionally involves removing a patient’s immune cells, modifying them in a...
Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung Completes Enrollment for Next-Gen Blood Cancer Drug Trial

Boryung announced on the 19th that it has completed patient enrollment for the Phase 2 clinical trial of its...
From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

From Returned Candidate to Homegrown Breakthrough: Hanmi’s ‘Epe’ Prepares to Challenge Wegovy and Mounjaro

Efpeglenatide, a drug candidate whose development rights were once returned by a global pharmaceutical giant, is...
New Parkinson’s Drug Cuts Daily “Off” Time by Nearly an Hour for Patients on Levodopa

New Parkinson’s Drug Cuts Daily “Off” Time by Nearly an Hour for Patients on Levodopa

You take your medication, but before long, stiffness returns and your hands begin to tremble.
Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters

Surgery Is Just the First Step in Lung Cancer: Why EGFR Mutation Testing Matters

Lung cancer is the second most commonly diagnosed cancer in South Korea and the leading cause of cancer mortality,...
Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical Nears Completion of Phase 2 IPF Trial for Bersiporosin, Readout Set for H1 2027

Daewoong Pharmaceutical has completed patient enrollment for the global Phase 2 clinical trial of bersiporosin...